-
公开(公告)号：US10092763B2
公开(公告)日：2018-10-09
申请号：US15630615
申请日：2017-06-22
Applicant: Cardiac Pacemakers, Inc.
Inventor： Jeffrey E. Stahmann , Keith R. Maile , Brendan Early Koop , Michael J. Kane , Jacob M. Ludwig , Paul Huelskamp
Abstract: Medical device systems and methods with multiple communication modes. An example medical device system may include a first medical device and a second medical device communicatively coupled to the first medical device. The first medical device may be configured to communicate information to the second medical device in a first communication mode. The first medical device may further be configured to communicate information to the second medical device in a second communication mode after determining that one or more of the communication pulses captured the heart of the patient.
-
公开(公告)号：US20180117336A1
公开(公告)日：2018-05-03
申请号：US15793199
申请日：2017-10-25
Applicant: CARDIAC PACEMAKERS, INC.
Inventor： Jacob M. Ludwig , Keith R. Maile
CPC classification number: A61N1/36146 , A61N1/3622 , A61N1/36521 , A61N1/371 , A61N1/37288 , A61N1/3756 , A61N1/3956
Abstract: A medical system may include a first medical device such as a leadless cardiac pacemaker (LCP) that is configured to pace a patient's heart and a second medical device that is configured to have a capture threshold capability. The second medical device may monitor the patient's heart to ascertain whether the pacing pulses from the first medical device are capturing the heart, and to send the first medical device instructions to alter an energy level of subsequent pacing pulses.
-
公开(公告)号：US09724522B2
公开(公告)日：2017-08-08
申请号：US15398355
申请日：2017-01-04
Applicant: Cardiac Pacemakers, Inc.
Inventor： Jeffrey E. Stahmann , Keith R. Maile , Brendan E. Koop , Michael J. Kane , Jacob M. Ludwig , Paul Huelskamp
CPC classification number: A61N1/37288 , A61N1/362 , A61N1/371 , A61N1/37205 , A61N1/37211 , A61N1/3727 , A61N1/3756
Abstract: Medical device systems and methods with multiple communication modes. An example medical device system may include a first medical device and a second medical device communicatively coupled to the first medical device. The first medical device may be configured to communicate information to the second medical device in a first communication mode. The first medical device may further be configured to communicate information to the second medical device in a second communication mode after determining that one or more of the communication pulses captured the heart of the patient.
-
公开(公告)号：US20170095673A1
公开(公告)日：2017-04-06
申请号：US15282105
申请日：2016-09-30
Applicant: Cardiac Pacemakers, Inc.
Inventor： Jacob M. Ludwig , Ron A. Balczewski , Todd W. Grotbeck , Keith R. Maile , Moira B. Sweeney
IPC: A61N1/39 , A61B5/042 , A61B5/0408 , A61B5/00
CPC classification number: A61N1/3987 , A61B5/0006 , A61B5/002 , A61B5/0031 , A61B5/0205 , A61B5/0408 , A61B5/042 , A61B5/046 , A61B5/0464 , A61B5/0816 , A61B5/1102 , A61B5/1116 , A61B5/4836 , A61B5/6805 , A61B5/686 , A61B5/7264 , A61B5/7275 , A61B2505/01 , A61B2560/0443 , A61B2560/0468 , A61N1/3925 , G16H20/60 , G16H40/63 , G16H40/67 , G16H50/20 , G16H50/70
Abstract: A medical system for providing a defibrillation therapy to a patient includes a cardiac monitoring device (CMD) configured to sense and record physiological data indicative of the patient's cardiac function. The CMD includes a communication component. The system also includes an external therapy device configured to deliver defibrillation therapy, and configured to be positioned external to and supported by the patient. The external therapy device includes an external therapy device communication component. The CMD communication component and the external therapy device communication component are configured to operatively couple the CMD and the external therapy device to one another, so as to work as a system to detect and treat fibrillation.
-
5.发明申请公开(公告)号：US20160228701A1
公开(公告)日：2016-08-11
申请号：US15015792
申请日：2016-02-04
Applicant: CARDIAC PACEMAKERS, INC.
Inventor： Paul Huelskamp , Jacob M. Ludwig , Lance E. Juffer , Keith R. Maile
CPC classification number: A61N1/3622 , A61N1/365 , A61N1/36514 , A61N1/37217 , A61N1/3756
Abstract: Systems and methods for treating arrhythmias are disclosed. In one embodiment an LCP comprises a housing, a plurality of electrodes for sensing electrical signals emanating from outside of the housing, an energy storage module disposed within the housing, and a control module disposed within the housing and operatively coupled to the plurality of electrodes. The control module may be configured to receive electrical signals via two or more of the plurality of electrodes and determine if the received electrical signals are indicative of a command for the LCP to deliver ATP therapy. If the received electrical signals are indicative of a command for the LCP to deliver ATP therapy, the control module may additionally determine whether a triggered ATP therapy mode of the LCP is enabled. If the triggered ATP therapy mode is enabled, the control module may cause the LCP to deliver ATP therapy via the plurality of electrodes.
Abstract translation: 公开了用于治疗心律失常的系统和方法。 在一个实施例中，LCP包括壳体，用于感测从壳体外部发出的电信号的多个电极，设置在壳体内的能量存储模块以及设置在壳体内并可操作地耦合到多个电极的控制模块。 控制模块可以被配置为经由两个或多个多个电极接收电信号，并确定所接收的电信号是否指示LCP递送ATP治疗的命令。 如果所接收的电信号指示LCP提供ATP治疗的命令，则控制模块可另外确定是否启用了LCP的触发ATP治疗模式。 如果触发的ATP治疗模式被启用，则控制模块可以使LCP通过多个电极传递ATP治疗。
-
Patent Agency Ranking
公开(公告)号：US11476927B2
公开(公告)日：2022-10-18
申请号：US16033852
申请日：2018-07-12
Applicant: CARDIAC PACEMAKERS, INC.
Inventor： Jacob M. Ludwig , Michael J. Kane , Brendan E. Koop , William J. Linder , Keith R. Maile , Jeffrey E. Stahmann
Abstract: Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.
-
公开(公告)号：US11338135B2
公开(公告)日：2022-05-24
申请号：US16167116
申请日：2018-10-22
Applicant: Cardiac Pacemakers, Inc.
Inventor： Brian L. Schmidt , Jacob M. Ludwig , Benjamin J. Haasl , Michael J. Kane
IPC: A61B18/12 , A61N1/32 , A61N1/36 , A61N1/04 , A61N5/02 , A61B18/18 , A61N1/375 , A61B18/14 , A61N1/05
Abstract: Embodiments herein relate to medical device systems including electric field shaping elements for use in treating cancerous tumors within a bodily tissue. In an embodiment, a medical device system for treating a cancerous tumor is described. The medical device system can include one or more electric field generating electrodes and an electric field shaping element configured to be implanted along with the one or more electric field generating electrodes. The electric field shaping element can be made from a material that alters the spatial area of tissue exposed to the electric field. Other embodiments are also included herein.
-
公开(公告)号：US20210038904A1
公开(公告)日：2021-02-11
申请号：US17083997
申请日：2020-10-29
Applicant: CARDIAC PACEMAKERS, INC.
Inventor： Brendan Early Koop , Paul Huelskamp , Lance Eric Juffer , Kyle Leonard Nelson , Keith R. Maile , Jacob M. Ludwig
Abstract: Implantable medical devices (IMD), such as but not limited to leadless cardiac pacemakers (LCP), subcutaneous implantable cardioverter defibrillators (SICD), transvenous implantable cardioverter defibrillators, neuro-stimulators (NS), implantable monitors (IM), may be configured to communicate with each other. In some cases, a first IMD may transmit instructions to a second IMD. In order to improve the chances of a successfully received transmission, the first IMD may transmit the instructions several times during a particular time frame, such as during a single heartbeat. If the second IMD receives the message more than once, the second IMD recognizes that the messages were redundant and acts accordingly.
-
公开(公告)号：US20190321649A1
公开(公告)日：2019-10-24
申请号：US16503236
申请日：2019-07-03
Applicant: Cardiac Pacemakers, Inc.
Inventor： Jacob M. Ludwig
IPC: A61N1/39 , A61B5/042 , A61N1/362 , A61B5/00 , A61B5/0464
Abstract: In an example, an apparatus is described that includes an implantable housing, a heart signal sensing circuit configured to sense intrinsic electrical heart signals, a ventricular tachyarrhythmia (VT) detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals, a processor configured to control delivery of an anti-tachyarrhythmia pacing (ATP) therapy based on the detected VT, and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock.
-
公开(公告)号：US10413743B2
公开(公告)日：2019-09-17
申请号：US15728238
申请日：2017-10-09
Applicant: Cardiac Pacemakers, Inc.
Inventor： Jacob M. Ludwig
Abstract: In an example, an apparatus is described that includes an implantable housing, a heart signal sensing circuit configured to sense intrinsic electrical heart signals, a ventricular tachyarrhythmia (VT) detector circuit, operatively coupled to the heart signal sensing circuit, the detector circuit operable to detect a VT based on the sensed heart signals, a processor configured to control delivery of an anti-tachyarrhythmia pacing (ATP) therapy based on the detected VT, and an energy delivery circuit configured to deliver the ATP therapy in response to the detected VT, wherein the apparatus does not include a shock circuit capable of delivering a therapeutically-effective cardioverting or defibrillating shock.
-
-
-
-
-
-
-
-
-
Search Results
48
records
(took 0.021 seconds)
